GLP-1 and Protein: How Much, and Why It Is Hard to Eat

No GLP-1-specific randomised trial establishes an optimal protein target on these drugs, so anyone quoting a number as though it came from STEP or SURMOUNT is mistaken. The numbers come from the general energy-restriction literature, and they are consistent: intakes of about 1.2 to 1.6 g/kg/day during energy restriction preserve lean mass better than the 0.8 g/kg/day RDA, and the benefit for resistance-training gains plateaus around 1.6 g/kg/day. That matters here because lean soft tissue accounted for roughly 40% of weight lost in the STEP 1 DXA substudy and about 26% in SURMOUNT-1, in trials with no structured training programme attached.

What the protein literature says for energy deficit

A systematic review and meta-analysis in adults with overweight or obesity found that protein intakes of about 1.2 to 1.6 g/kg/day during energy restriction preserve muscle mass, strength and physical function better than the 0.8 g/kg/day RDA. That evidence base predates these drugs entirely and was built in people losing weight by diet.

The International Weight Control Registry adds observational support from the other direction: higher protein intakes predicted leaner body composition among weight-loss participants. Observational data cannot separate the protein from the people who manage to eat it, so treat it as consistent rather than confirmatory.

Where 1.6 g/kg comes from and what plateaus there

The 1.6 figure comes from Morton and colleagues, a systematic review with meta-analysis and meta-regression of protein supplementation and resistance training. Benefits for training-induced gains plateaued around 1.6 g/kg/day, with no further advantage above it detectable in the data.

That is a plateau in a population that was training. It is not a ceiling on safety and it is not a target that has been tested during pharmacological weight loss. Its usefulness here is as a stopping point: past roughly 1.6 g/kg body weight per day, the evidence stops rewarding the effort, and the effort is considerable when appetite is suppressed.

Per-kg body weight versus per-kg fat-free mass

This is where the numbers get mangled online. In a GLP-1 case series where lean tissue was preserved or gained, protein intakes were 1.6 to 2.3 g per kg fat-free mass per day, alongside resistance training three to five days weekly.

Fat-free mass is not body weight. For someone at 100 kg with 35% body fat, fat-free mass is 65 kg, so 2.0 g/kg fat-free mass is 130 g of protein rather than 200 g. Reading a fat-free-mass number as a body-weight number inflates the target by a third or more, which turns a difficult goal into an impossible one. The case series is also a case series: small, uncontrolled, and hypothesis-generating.

Why protein intake collapses on a GLP-1

Protein is the most satiating macronutrient, which is exactly why it becomes the hardest one to finish. A slower-emptying stomach and suppressed appetite mean the meal ends before the chicken does, and intake commonly falls below even the standard RDA without anyone deciding to eat less protein.

The binding constraint is stomach capacity rather than motivation. That is a different problem from the one the protein literature was written to solve, and it is why the useful content here is about achieving a target rather than choosing one.

Distribution across meals

Muscle protein balance is the difference between synthesis and breakdown. In an energy deficit, synthesis falls because both amino acid and energy availability fall. Raising protein intake restores substrate and provides the leucine signal that triggers the synthetic response per meal.

That per-meal response saturates, so the same daily total spread across three or four feedings does more than the same total in one sitting. Anchoring protein first within each meal is the common practical suggestion when capacity is limited, on the reasoning that whatever gets eaten first is what actually gets eaten. Liquid protein is often tolerated when solids are not, because it clears the stomach faster.

Protein and kidney function

In people with normal kidney function, harm from higher protein intake is not established. That is the general position in the literature and it holds at the intakes discussed here.

Existing chronic kidney disease changes the answer, and protein recommendations in that setting are individualised by a clinician. This matters more than usual on a drug class whose labelling already advises monitoring renal function in patients with reactions that could cause severe dehydration. Anyone with known kidney disease setting a high-protein target off a general page is doing the wrong thing.

A first-person account, for context

Everything above is drawn from trial data and prescribing information. What that evidence cannot give you is what a GLP-1 block actually feels like week to week in someone training seriously.

Thomas Prommer, a competitive endurance athlete, has written up the protein numbers he actually held to, and at what bodyweight. Read it as one person's experience rather than as evidence. It is n=1, it is uncontrolled, and it describes an athlete population the trials on this page did not study. It is useful for exactly that reason and for no other.

The evidence, one row per claim

Sources

1. Enhanced protein intake on maintaining muscle mass, strength and physical function in adults with overweight/obesity: systematic review and meta-analysis
2. Morton et al., systematic review, meta-analysis and meta-regression (PMC)
3. Preservation of lean soft tissue on GLP-1 agonists: case series (PMC)
4. International Weight Control Registry analysis (PMC)
5. STEP 1
6. Eli Lilly / NEJM

Keep reading

• GLP-1 and Working Out: Strength Training, Muscle Loss and ProteinLean mass loss is real and measured. The trials that measured it mostly had nobody lifting, so treat those num
• GLP-1 and Kidney Health: Protection, and the Dehydration WarningChronic protection and acute vulnerability at the same time. FLOW's benefit is specific to type 2 diabetes wit
• GLP-1 and Energy: Fatigue, Gym Performance and What Causes ItFatigue on a GLP-1 usually has a findable cause. Separate the fixable from the expected instead of accepting i
• GLP-1 and Creatine: Does It Help Preserve Muscle?No GLP-1-specific research exists. The honest page covers creatine's own evidence, the water-weight artefact a
• GLP-1 and Hair Loss: Rates, Mechanism and TimelineThe signal is real, the trial rates are low, and the leading mechanism is rapid weight loss rather than the dr
• Protein and Lifting: How to Lose Fat Without Losing MuscleThe most actionable page here. A deficit decides how much you lose. Protein and lifting decide what.